SCHEMBL5096741

SCHEMBL5096741

CC(=O)N(c1ccc(C(=O)O)cc1C)C1CCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.62
OPRM1 P35372 1/20 0.43
RAB9A P51151 5/20 0.40
NPC1 O15118 4/20 0.39
PKM P14618 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 2/20 0.39
PAX8 Q06710 2/20 0.39
S1PR1 P21453 2/20 0.39
APAF1 O14727 1/20 0.39
TDP2 O95551 1/20 0.39
S1PR4 O95977 1/20 0.39
HSP90AA1 P07900 1/20 0.39
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
CACNA1B Q00975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5111276 0.99 LMNA (0.60) LMNAOPRM1RAB9ANPC1PKM
SCHEMBL5885742 0.81 LMNA (0.64) LMNAOPRM1RAB9ANPC1PKM
SCHEMBL6554480 0.79 SMN1; SMN2 (0.41) LMNAOPRM1RAB9ANPC1NPSR1
SCHEMBL7557798 0.73 ALDH1A1 (0.47) LMNANPSR1L3MBTL1ALDH1A1MAPT
SCHEMBL2120103 0.71 HCAR3 (0.57) NPC1KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL31003829 0.70 KMO (0.49) KDM4EL3MBTL1ALDH1A1S1PR1HTT
SCHEMBL27533046 0.70 LMNA (0.87) LMNAOPRM1RAB9ANPC1PKM
SCHEMBL4946903 0.69 KMO (0.54) RAB9ANPC1L3MBTL1ALDH1A1S1PR1
SCHEMBL1948888 0.69 LMNA (0.54) LMNARAB9ANPC1PKMNPSR1
SCHEMBL4951622 0.68 KMO (0.57) RAB9ANPC1KDM4EL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132496-A1 CARBOXYLIC ACID AMIDES, THE PREPARATION THEREOF, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2008-06-05 US disclosed
US-7326791-B2 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) 2008-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132496-A1 CARBOXYLIC ACID AMIDES, THE PREPARATION THEREOF, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS F12, F11, F2 LMNA 2898/4885OPRM1 500/4885RAB9A 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.